AKANDA CORP. UNDERWRITING AGREEMENTUnderwriting Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products • New York
Form of Warrant AgreementWarrant Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products • California
THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [*], 2022 (THE DATE OF ISSUANCE). VOID AFTER 5:00 P.M., EASTERN TIME, [*], 2027 (THE DATE THAT IS FIVE YEARS FROM THE DATE ON WHICH THE REGISTRATION STATEMENT IS DECLARED EFFECTIVE).
RA/65218.1/65871948.5 Service agreement Dated 2 June 2021 Canmart Limited (Company) Halo Labs Inc. (Guarantor) Tejinder Virk (Executive)Service Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products • England and Wales
Memorandum of UnderstandingMemorandum of Understanding • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products
This Memorandum of Understanding (“MOU”) sets the terms and understanding between Akanda or its nominees and Cellen to establish a formal working relationship to optimize in medical cannabis supply chain activities and pursue opportunities in this regard within the territory of UK.
DATED: 29 September 2020 LOUISA MADIAKO MOJELA (‘the Lender”) AND BOPHELO BIO SCIENCE & WELLNESS PTY LTD (“the Borrower”)Loan Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products
The Lender has agreed to provide the Borrower with a short term facility in an aggregate amount of upto ZAR 2,000,000 (two million rands) which shall be provided either in one lumpsum amount or in parts in accordance with the terms of this agreement.
OFF-TAKE AGREEMENTOff-Take Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products
THIS OFF-TAKE AGREEMENT (this “Agreement”), dated 3rd August 2020, (the “Effective Date”) is made and entered into by and between Medcan Ltd,a company incorporate in the Republic of Malta with registration number C 73431 (“Medcan”) and Bophelo Bio Science and Wellness Pty Ltd, a company incorporated in the Kingdom of Lesotho with the registration number 2018/62924 (“BOPHELO”), both of whom are hereinafter collectively referred to as the “Parties” and any one of which shall be referred to as a “Party” as the context may require. This Agreement shall apply to each and every delivery and sale of Bulk Extract (defined in “DEFINITIONS” below) by BOPHELO to Medcan and shall constitute the entire agreement between the Parties with respect to the purchase and sale of Bulk Biomass.
AGREEMENT OF SUBLEASESublease Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products
Heads of Terms Between: Akand Corp. (“Akanda") 1a,1b Learoyd Road, New Romney, TN28 8XU, United Kingdom Cellen Limited (“Cellen“ or “the Company”) {insert address}Heads of Terms • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products • England and Wales
These heads of terms set out the main terms and conditions on and subject to which Akanda will provide Cellen with a line of credit subject to meeting the criteria set out herein (the “Bridge Loan Facility”).
SERVICE, REFINEMENT AND DISTRIBUTION AGREEMENT between represented by its CEO Philip Schetter Heinrich-Mann-Str. 12, 14532 Kleinmachnow, GermanyService, Refinement and Distribution Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products
The terms “CANTOURAGE” and “BOPHELO” include the respective affiliated companies of CANTOURAGE or BOPHELO pursuant to Sections 15 AktG et seqq. [Aktiengesetz - Stock Corporations Act]. Those companies in which CANTOURAGE holds a share of at least 50 % are also deemed to be affiliated companies of CANTOURAGE.
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products • Ontario
THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”), is made as of November 3, 2021 (the “Effective Date”), by and among AKANDA CORP., an Ontario corporation (the “Company”), and HALO COLLECTIVE INC., an Ontario corporation, as further identified on Schedule A hereto (the “Investor”).
ContractSubscription Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products • Ontario
Certain portions of this exhibit have been redacted in accordance with Item 601(a)(6) of Regulation S-K. This information is not material and disclosure of such information would constitute an unwarranted invasion of personal privacy. “[*]” indicates that information has been redacted.
INDEMNITY AGREEMENTIndemnity Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products • Ontario
Akanda Corp. a corporation incorporated under the Business Corporations Act (Ontario) (hereinafter called the "Corporation")
CONTRACT OF EMPLOYMENT Between NewCo (“Employer” or “Company” or “NewCo”) and Dr. Aslihan Akkar-Schenkl (“Employee”)Contract of Employment • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products
ContractShare Purchase Agreement • January 31st, 2022 • Akanda Corp. • Medicinal chemicals & botanical products • Ontario
Certain portions of this exhibit have been redacted in accordance with Item 601(a)(6) of Regulation S-K. This information is not material and disclosure of such information would constitute an unwarranted invasion of personal privacy. “[*]” indicates that information has been redacted.
